CBX, the cannabis trading platform, opens up its capital via an STO
CBX, a Geneva-based company founded by Jonas Duclos and Kevin Goetelen, also co-founders of CBD420, is a platform for buying and selling raw materials and products derived from hemp and cannabis.
Based on the premise that regulations in the sector and the level of health safety were more than a little random, the company set out to develop an exchange platform whose main focus is the quality of the product exchanged. Through compliance checks, analyses, transparency certifications and quality labels, the CBX platform aims to be the central tool guaranteeing a controlled environment and the tools to bring transparency from the field to the shop shelf.
«The industry needs to build legitimacy and trust in order to democratize cannabis use. And trust will only exist with relevant testing, certifications and trustworthy labels. I'm proud to present a solution that will enable all industry players to operate in a common market with guaranteed transparency,» says Jonas Duclos.
With almost 4,000 members already, the two partners are now looking for funds to develop their promising and fast-growing business. To this end, they decided to launch an STO to Secured Tokens Offering, to raise funds via blockchain, and open 20% of its capital to the public. Tokenization« enables the company to digitize its shares via blockchain, while satisfying security and transparency requirements... People who buy these tokens will become full shareholders in the company.
To participate in the fundraising, CBX has posted an instruction manual. 2,000 Tokens are on sale at 850 Swiss francs (820 euros) each, and subscriptions will be validated on a first-come, first-served basis. The STO runs until December 31, or until all 2,000 tokens are sold out.
-
Business3 weeks ago
Cronos Completes the Acquisition of CanAdelaar for 57.5 million euros
-
Cannabis in France3 weeks ago
France already has 3,000 cannabis retail outlets. None of them are legal.
-
Cannabis in Quebec2 weeks ago
Cannabis: What France Could Learn from Quebec, Eight Years After Legalization
-
Cannabis in the U.S.4 weeks ago
A DEA report confirms that there are no fatal cannabis overdoses
-
Studies on cannabis4 weeks ago
Cannabis Oil and Endometriosis: A Promising Study for Pain Relief
-
Cannabis in France4 weeks ago
CBD in France: Traceability, Retail Stores, THC and Driving… What the New Bill Proposes
-
Business4 weeks ago
Tilray is accelerating its operations in Europe thanks to a license in Portugal
-
Cannabis in New Zealand2 weeks ago
Chronic Pain: New Zealand Is Testing Cannabis to Improve Sleep


You must be logged in to post a comment Login